Skip to main content
. 2020 Jun 10;37(7):3404–3416. doi: 10.1007/s12325-020-01395-x

Fig. 1.

Fig. 1

Study design and treatment schema. ASCT autologous stem cell transplant, ISS International Staging System, IV intravenously administered, Q4W every 4 weeks, SC subcutaneously administered, SRE skeletal-related event